Back to Atlas
selvita.com·Tracked since May 27, 2026

Selvita

Mentions

1

Across all reports

Quality Score

15/ 100

New

First Seen

May 27, 2026

Indexed in atlas

Last Seen

3h ago

Most recent reference

Positioning

Synthesized from 1 mention

Selvita provides fee-for-service virtual screening using their proprietary TADAM AI platform. They target companies that prefer outsourcing over in-house tools. Pricing is project-based, typically $50k-$200k per screen. They also offer integrated drug discovery services.

Strengths

3 cited
  • Full-service CRO
  • AI platform
  • Established client base

Weaknesses

3 cited
  • High cost
  • No self-service tool
  • Long turnaround

Recent mentions

Showing 1 of 1
  • adjacent
    3h ago

    Virtual Screening Platform for Drug Discovery Teams

    virtualscreeningplatformdrugdiscoveryteams

Validate something like Selvita

Use Selvita as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.